Author

C. G. Richer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

C. Y. Kang· 1 shared E. J. Arts· 1 shared G. N. Kim· 1 shared K. A. Parham· 1 shared K. Wu· 1 shared M. Ninkov· 1 shared N. Saeedian· 1 shared R. M. Troyer· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

C. Y. Kang

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Monovalent and trivalent VSV-based COVID-19 vaccines elicit potent neutralizing antibodies and immunodominant CD8+ T cells against diverse SARS-CoV-2 variants

K. A. Parham, G. N. Kim, N. Saeedian, M. Ninkov, C. G. Richer, Y. Li, K. Wu, R. Rashu, S. D. Barr, E. J. Arts, S. M. M. Haeryfar, C. Y. Kang, R. M. Troyer

This study evaluates rVSV-based vaccines against SARS-CoV-2 variants, showing potent neutralizing antibodies and CD8+ T cell responses across multiple variants.

bioRxiv · Jul 19, 2022 · PreprintImmunology